Ledger.Open graph →
SEC Form D · filed October 2, 2024

Arda Therapeutics, Inc

Offering
$43.4M
Sold
$43.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Carlos, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Adam Freund · San Carlos, CAExec · DirectorVineeta Agarwala · San Carlos, CADirectorAdam Freund · San Carlos, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗